Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|||
| Income Statement [Abstract] | ||||||
| Revenue | $ 41,315 | |||||
| Cost of Sales | 34,192 | |||||
| Gross profit | 7,123 | |||||
| Operating expenses | ||||||
| Wages and salaries | 486,521 | 603,242 | 1,205,741 | 2,319,026 | ||
| Consulting | 177,215 | 147,190 | 363,411 | 1,032,210 | ||
| Professional fees | 112,361 | 277,694 | 442,090 | 1,026,044 | ||
| Office and administrative | 285,186 | 191,829 | 864,983 | 821,358 | ||
| Investor and public relations | 61,814 | 61,319 | 104,460 | 451,184 | ||
| Depreciation and amortization | 169,248 | 172,096 | 499,187 | 512,695 | ||
| Share based compensation | 63,552 | 80,537 | 127,674 | 565,861 | ||
| Sales and marketing | 20,281 | 11,242 | 96,107 | 173,568 | ||
| Lease expense | 782 | 73,261 | 59,358 | 222,535 | ||
| Travel and entertainment | 23,757 | 3,813 | 31,915 | 104,938 | ||
| Shareholder and regulatory | 13,431 | 35,857 | 98,880 | 114,674 | ||
| Research and development | 54,036 | (27,046) | 58,130 | 22,312 | ||
| Intangible asset impairment (Note 6) | 4,137,271 | 4,137,271 | ||||
| Operating expenses | 5,605,455 | 1,631,034 | 8,089,207 | 7,366,405 | ||
| Operating loss | (5,605,455) | (1,631,034) | (8,082,084) | (7,366,405) | ||
| Other expenses | ||||||
| Accretion of interest on debentures (Note 9) | 469,684 | 2,064,936 | 2,672,765 | 6,045,214 | ||
| Loss on conversion of convertible debt (Note 9) | 235,376 | 108,125 | 1,627,858 | 541,730 | ||
| Loss on debt extinguishment (Note 9) | (75,119) | 2,223,250 | ||||
| (Gain) loss on extinguishment of warrant liability | (14,769) | (14,769) | ||||
| Change in fair value of derivative liabilities (Note 12) | (505,628) | (326,042) | (1,198,554) | (6,159,067) | ||
| Loss on long-term investment | 97,488 | 97,488 | ||||
| Foreign exchange gain | 63,834 | 25,472 | (22,918) | (1,317) | ||
| Other loss | 4,252 | |||||
| Write-off of inventory | 38,470 | |||||
| Write-off of deposit (Note 4) | 12,000 | |||||
| Other income | (28,956) | (10,472) | (102,762) | (64,887) | ||
| Net loss | (5,847,365) | (3,493,053) | (13,407,164) | (7,740,078) | ||
| Other comprehensive income (loss) | ||||||
| Foreign currency translation | 179,950 | (226,286) | (228,699) | 84,719 | ||
| Comprehensive loss attributable to common shareholders | $ (5,667,415) | $ (3,719,339) | $ (13,635,863) | $ (7,655,359) | ||
| Basic net loss attributed to common share | $ (0.06) | $ (4.03) | $ (0.27) | $ (12.58) | ||
| Diluted net loss attributed to common share | $ (0.06) | $ (4.03) | $ (0.27) | $ (12.58) | ||
| Weighted average number of common shares outstanding - basic | [1] | 92,015,605 | 867,110 | 50,333,281 | 615,152 | |
| Weighted average number of common shares outstanding - diluted | [1] | 92,015,605 | 867,110 | 50,333,281 | 615,152 | |
| ||||||
| X | ||||||||||
- Definition Accretion interest on debentures. No definition available.
|
| X | ||||||||||
- Definition Consulting fees or expenses. No definition available.
|
| X | ||||||||||
- Definition Gain loss on conversion of convertible debt. No definition available.
|
| X | ||||||||||
- Definition Gain loss on extinguishment of warrant liability. No definition available.
|
| X | ||||||||||
- Definition Investor and public relations. No definition available.
|
| X | ||||||||||
- Definition Shareholder and regulatory. No definition available.
|
| X | ||||||||||
- Definition Travel and entertainment. No definition available.
|
| X | ||||||||||
- Definition Write off of deposit. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of operating lease expense. Excludes sublease income. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|